β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study.
about
Pharmacological management of hypertension in pregnancy.Evidence for a critical role of catecholamines for cardiomyocyte lineage commitment in murine embryonic stem cells.Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy.The unexpected pitter patter: new-onset atrial fibrillation in pregnancy.Accuracy of ICD-9-CM coding to identify small for gestational age newbornsPharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application.Use of medication for cardiovascular disease during pregnancy.Propranolol and oxytocin versus oxytocin alone for induction and augmentation of labor: a meta-analysis of randomized trials.In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review.Nitrosatable Drug Exposure during Pregnancy and Preterm and Small-for-Gestational-Age Births.Dwarfism and insulin resistance in male offspring caused by α1-adrenergic antagonism during pregnancy.Pregnancy in women with an implantable cardioverter-defibrillator: is it safe?Ambulatory BP monitoring and clinic BP in predicting small-for-gestational-age infants during pregnancy.Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997-2011.Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction.Effects of β-adrenergic receptor drugs on embryonic ventricular cell proliferation and differentiation and their impact on donor cell transplantation.Management of hyperthyroidism in pregnancy.Maternal caffeine consumption and small for gestational age births: results from a population-based case-control study.
P2860
Q34746979-190963B8-B6B7-4791-BC99-3F13743875B9Q34926288-EEE4B05D-BF2E-4ECA-BAE0-0121741DDE77Q35056331-4C33A4C4-3345-477A-A00B-79BB51E13181Q35549833-DDAB0B34-D2C0-408E-97D4-B65C8E13FF14Q35945479-3986229C-9DD8-4D03-813C-471651567967Q38494265-20D0AB8E-68BF-4875-A771-0B9FC526E64AQ38639052-4F8020E0-5058-44BF-A74B-750D3FFB5211Q38676629-663F584B-3EB5-4FAC-B009-F14F9A2FEC4DQ38702465-877242EE-6169-4703-9425-6C321BAFA8CDQ41708862-5CD37963-9D32-48B8-8879-D1B2EB3548AFQ42377850-B059F82A-D3D5-4A1A-A083-FBCBDCF69059Q47822896-2782CC62-21C4-400A-AF8D-1AF3844EDC5BQ47986851-D8CFBC4C-E315-4A3D-8E86-6ADD86FA68DCQ50075248-35D93436-A7E4-4A22-9476-A0FA6972AA51Q50735977-1C6D1A7C-7D46-41DC-ACDF-F17303091D81Q51102078-F0D3C58E-4E21-46F8-A735-4A8C005CBD15Q53310413-C0BAE122-1928-463C-9D47-D7653501F7BEQ55404357-740CFB7E-EBAA-432E-9F3B-8A8F9C9070C6
P2860
β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
β-Blocker treatment during pre ...... population-based cohort study.
@ast
β-Blocker treatment during pre ...... population-based cohort study.
@en
type
label
β-Blocker treatment during pre ...... population-based cohort study.
@ast
β-Blocker treatment during pre ...... population-based cohort study.
@en
prefLabel
β-Blocker treatment during pre ...... population-based cohort study.
@ast
β-Blocker treatment during pre ...... population-based cohort study.
@en
P2093
P2860
P50
P1433
P1476
β-Blocker treatment during pre ...... population-based cohort study.
@en
P2093
Espen Jimenez-Solem
Kasper Brødbæk
Morten Petersen
P2860
P356
10.1136/BMJOPEN-2012-001185
P577
2012-07-19T00:00:00Z